Irinotecan plus fluorouracil‐based regimen as second or third‐line chemotherapy for recurrent or metastatic esophageal squamous cell carcinoma

Background No standard second‐line regimen exists for the treatment of advanced esophageal squamous cell carcinoma (ESCC). The aim of this study was to evaluate the efficacy and safety of irinotecan and fluorouracil‐based chemotherapy as a second or third‐line regimen for advanced ESCC patients. Met...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Thoracic cancer 2016-03, Vol.7 (2), p.246-250
Hauptverfasser:	Wang, Xi, Wang, Xinwei, Huang, Jing
Format:	Artikel
Sprache:	eng
Schlagworte:	5‐Fluorouracil Cancer Chemotherapy Development and progression Diarrhea Esophageal cancer esophageal squamous cell carcinoma irinotecan Metastasis Original Squamous cell carcinoma
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!